Management of Syphilis as an Outpatient

Standard Outpatient Treatment Approach

The Centers for Disease Control and Prevention recommends a single intramuscular injection of benzathine penicillin G 2.4 million units for primary, secondary, and early latent syphilis, which can be administered in any outpatient setting 1, 2.
For late latent syphilis or syphilis of unknown duration, the treatment consists of three doses of benzathine penicillin G 2.4 million units IM given at weekly intervals, with all injections administered in the outpatient setting 3, 2, 4.
The American College of Physicians suggests that penicillin-allergic patients with primary or secondary syphilis can be treated with doxycycline 100 mg orally twice daily for 14 days in an outpatient setting 2, 5.

Patients with confirmed neurosyphilis require intravenous aqueous crystalline penicillin G 18-24 million units per day, typically necessitating inpatient hospitalization, although some patients may receive outpatient parenteral antibiotic therapy 6.
The Infectious Diseases Society of America recommends that patients with symptomatic cardiovascular syphilis or gummatous disease may require inpatient evaluation and management in consultation with infectious disease specialists 6, 7.

The Centers for Disease Control and Prevention recommends clinical and serologic evaluation using nontreponemal tests at 6 and 12 months after treatment for early syphilis, and at 6, 12, and 24 months for late latent syphilis 2, 5.
For HIV-infected patients, more frequent monitoring is required, with clinical and serologic evaluation at 3, 6, 9, 12, and 24 months 8, 5.

All patients with syphilis must be tested for HIV infection at the time of diagnosis, as co-infection is common and affects monitoring frequency, according to the American College of Physicians 1, 2, 5.
Sexual partners exposed within 90 days prior to diagnosis should receive presumptive treatment with benzathine penicillin G 2.4 million units IM in the outpatient setting 9.

Pregnant women with syphilis should be treated in the outpatient setting with benzathine penicillin G using the same stage-appropriate regimens, as recommended by the American College of Obstetricians and Gynecologists 2, 8.
Penicillin-allergic pregnant women must be desensitized and treated with penicillin rather than using alternative antibiotics, as no other regimen reliably prevents congenital syphilis, according to the Centers for Disease Control and Prevention 2, 8, 10.

Early latent syphilis is defined as a latent infection acquired within the preceding 12 months, confirmed by documented seroconversion from a negative to a positive non‑treponemal test (e.g., RPR) within that timeframe. The Centers for Disease Control and Prevention (CDC) uses this criterion to classify cases. 11

For patients classified with early latent syphilis, the CDC recommends a single intramuscular injection of benzathine penicillin G 2.4 million units, which provides adequate treponemicidal blood levels and can be administered in an outpatient setting. 11
In non‑pregnant patients with a documented penicillin allergy, the CDC recommends doxycycline 100 mg orally twice daily for 14 days as the preferred alternative regimen. 11

A comprehensive mucosal examination of the oral cavity, perianal area, perineum, genital mucosa (vagina in women, foreskin in uncircumcised men) should be performed to exclude lesions that would indicate secondary rather than latent syphilis. This examination is mandated by CDC guidance. 11

Treatment success is defined by a ≥ fourfold decline in non‑treponemal test titer (e.g., a reduction from 1:16 to ≤ 1:4) within 12 months after therapy, using the baseline titer obtained on day 0 as the reference point. This serologic endpoint is specified by the CDC. 11

The CDC advises that nontreponemal titers alone should not be used to distinguish early from late latent syphilis; the critical factor is documented timing of seroconversion within the prior year. 11